Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02080845 · ClinicalTrials.gov registry record · NA
Effects of a Cocoa Shot on the Human Brain 2
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02080845 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 24 participants.
The verdict
NCT02080845, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The Hershey Company is interested in investigating the effects of various chocolate beverages on brain physiology and cognitive function. The main substances in the drinks that are known to influence the brain are caffeine and related chemicals such as theobromine. Caffeine and chemicals related to caffeine are all naturally occurring and all potentially alter brain physiology. This study will evaluate changes in brain blood flow and cognition following the consumption of drinks with various combinations of the Primary Ingredients. The study proposed here will evaluate ingredients in a 4-arm cross-over double-blind design in an attempt to understand the differential effects of these compounds in chocolate drinks.
Interventions
- DIETARY_SUPPLEMENT low theobromine
- DIETARY_SUPPLEMENT no caffeine
- DIETARY_SUPPLEMENT high caffeine
- DIETARY_SUPPLEMENT no theobromine
- DIETARY_SUPPLEMENT high theobromine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02080845
The ClinicalTrials.gov registry entry for NCT02080845 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which low theobromine is the first listed.
NCT02080845 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02080845 about?
NCT02080845 is a clinical study titled "Effects of a Cocoa Shot on the Human Brain 2". The Hershey Company is interested in investigating the effects of various chocolate beverages on brain physiology and cognitive function. The main substances in the drinks that are known to influence the brain are caffeine and related chemicals such as theobromine. Caffeine and chemicals related to ...
What is the current status of trial NCT02080845?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2014-03. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02080845?
The interventions under investigation include: low theobromine (DIETARY_SUPPLEMENT), no caffeine (DIETARY_SUPPLEMENT), high caffeine (DIETARY_SUPPLEMENT), no theobromine (DIETARY_SUPPLEMENT), high theobromine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02080845?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.